Suche
Kategorie
981 Treffer
×
Forschungsprojekte
×
aktiv
×
Johannes Gutenberg-Universität Mainz
×
Katholische Hochschule Mainz
×
Theologische Fakultät Trier
- ARROW 2 Trial (#1116)
- Munder, Markus; Weisel, Katja; (2019 - 2040)
- Tumorantigene bei AML/MDS/MM (#1168)
- Wagner-Drouet, Maria; (2019 - 2040)
- DLBCL CD20+ ImbruVeRCHOP-Trial (#757)
- Heß, Georg; (2019 - 2040)
- INCB 01158-206 (#1151)
- Munder, Markus; (2019 - 2040)
- IMI.Gel001 (#1264)
- Radsak, Markus; (2019 - 2040)
- MPNSG (BiO)-Project in BCR-ABL1-negative Myeloid Neoplasms (#1141)
- Radsak, Markus; (2019 - 2040)
- Vision (#731)
- Alt, Jürgen; (2019 - 2040)
- ADVANCE II (#512)
- Wagner-Drouet, Maria; (2019 - 2040)
- BMS CA17-078: A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle Invasive Bladder Cancer
- Tsaur, Igor; Höfner, Thomas; Jäger, Wolfgang; (2019 - 2025)
- rrMCL PI3K Inhibitor_ CITADEL-205 / INCB 50465-205 (#767)
- Heß, Georg; (2019 - 2040)
- TOP-ART, NCT-PMO-1603 (#774)
- Kindler, Thomas; (2019 - 2040)
- GS-US-352-4365 (#788)
- Kindler, Thomas; (2019 - 2040)
- BMBF (FKZ: 13GW0403B): New Generation of an Artificial Skin Kit: Actively Induced Tissue Reconstruction (SKIN-ENERGY)
- Wang, Xiaohong; Müller, E.G.; (2019 - 2024)
- GO29781 (#795)
- Heß, Georg; (2019 - 2040)
- OLYMP-1 (#770)
- Heß, Georg; (2019 - 2040)
- DUO-O
- Hasenburg, Annette; Almstedt, Katrin; (2019 - 2027)
- Molecular and clinical analysis of papillary thyroid carcinoma
- Musholt, J.; Staubitz, Julia; (2018 - 2025)
- Stellar Teens - CNTO1275PSO4056 - NIS
- Staubach-Renz, Petra; (2018 - 2024)
- GMMG-CONCEPT (#693)
- Munder, Markus; (2018 - 2025)
- PRAN-16-52 (#650)
- Kindler, Thomas; (2018 - 2040)
- Römisch-Mittelalterliche Wurzeln von Stadecken
- Haupt, Peter; (ab 2018)
- Allo-MM-PostCy-Study (#763)
- Wagner-Drouet, Maria; (2018 - 2040)
- FLT3 Maintenance (#702)
- Wagner-Drouet, Maria; (2018 - 2040)
- SAKK 36/13 (#730)
- Heß, Georg; (2018 - 2040)
- 1336.11 (#662)
- Alt, Jürgen; (2018 - 2040)
- ACE-LY-308 (#679)
- Heß, Georg; (2018 - 2040)
- LB-Y5-025 (#751)
- Teschner, Daniel; (2018 - 2040)
- Impassion 030 Alexandra
- Schmidt, Marcus; Almstedt, Katrin; (2018 - 2026)
- AGO Ovar 22: A Phase III, multicenter, randomized, study of Atezolizumab versus placebo administered in combination with Paclitaxel, Carboplatin and Bevacizumab to patients with newly diagnosed Stage III or Stage IV ovarian, Fallopian Tube or primary Peritoneal Cancer
- Hasenburg, Annette; Battista, Marco; (2018 - 2025)
- Römisch-frühmittelalterliche Besiedlung im Umfeld der Kaiserpfalz Ingelheim
- Haupt, Peter; (ab 2017)
- Epigenetische Kontrolle leukämogener Genexpression durch Menin und MLL1-Komplexpartner-Proteine
- Kühn, Michael; (2017 - 2024)
- Frühe Eisengewinnung im Ingelheimer Wald
- Haupt, Peter; (ab 2017)
- MaiCo-MR
- Emrich, Tilman; (2017 - 2025)
- Ruxo-BEAT trial (#593)
- Kindler, Thomas; (2017 - 2040)
- Untersuchung zum HLA-DP-Mismatch bei allogener Stammzelltransplantation (#725)
- Wagner-Drouet, Maria; (2017 - 2040)
- JETS-Studie (#681)
- Wagner-Drouet, Maria; (2017 - 2040)
- AML_MDM2 antagonist, WO29519 Cytarabine (#643)
- Kindler, Thomas; (2017 - 2040)
- DETECT V /Chevendo
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- COMPASS
- Battista, Marco; Hasenburg, Annette; (2017 - 2025)
- Merit
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- ImPassion131
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- Fandango
- Battista, Marco; (2017 - 2025)
- Ruxo-allo-Studie (#631)
- Wagner-Drouet, Maria; (2017 - 2040)
- Precycle
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- SHAPE
- Hasenburg, Annette; Roxanna, Schwab; Seeger, Alexander; (2017 - 2025)
- REGSA
- Battista, Marco; Hasenburg, Annette; (2017 - 2025)